Ads
related to: Treatment Macular Degeneration- Wet AMD FAQs
Get Answers To Frequently Asked
Questions About Wet AMD
- Appointment Tips
Get Tips And Useful Information
To Talk to your Retina Specialist
- Sign Up For More Info
Sign Up Today To Receive More
Resources And Information
- Financial Assistance
Learn About Financial Support
That May Be Available To You
- Wet AMD FAQs
Search results
Skye Bioscience (NASDAQ:SKYE) Earns Outperform Rating from Analysts at Oppenheimer
ETF DAILY NEWS· 5 days agoOppenheimer assumed coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a report...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives $46.43 Consensus Price Target from Analysts
ETF DAILY NEWS· 4 days agoOutlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eight analysts that are currently covering the company, Marketbeat.com ...
Kenneth T. Mills Sells 15,000 Shares of REGENXBIO Inc. (NASDAQ:RGNX) Stock
ETF DAILY NEWS· 2 days agoREGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) CEO Kenneth T. Mills sold 15,000 shares of the business’s stock in a transaction on Monday, April 15th. Following the transaction, the chief executive ...
Salman Rushdie: I dreamt about being stabbed just before the attack
Daily Telegraph· 5 days agoIn August 2022, two days before he was due to appear at an event in Chautauqua, a small town in...
Cognition Therapeutics (NASDAQ:CGTX) and Black Diamond Therapeutics (NASDAQ:BDTX) Head to Head...
ETF DAILY NEWS· 3 days agoCognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) are both small-cap medical companies, but which is the superior investment ...
REGENXBIO (NASDAQ:RGNX) Stock Price Down 3.1% Following Insider Selling
ETF DAILY NEWS· 20 hours agoREGENXBIO Inc. (NASDAQ:RGNX – Get Free Report)’s share price was down 3.1% on Thursday after an insider sold shares in the company. The company traded as low as $16.21 and last traded at $16.50 ...
Vanguard Group Inc. Has $2.94 Million Stock Position in Kodiak Sciences Inc. (NASDAQ:KOD)
ETF DAILY NEWS· 4 days agoVanguard Group Inc. lifted its holdings in shares of Kodiak Sciences Inc. (NASDAQ:KOD – Free Report) by 0.2% during the 3rd quarter, according to the company in its most recent 13F filing with ...
Akari Therapeutics (NASDAQ:AKTX) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical ...
Apellis Pharmaceuticals (NASDAQ:APLS) Given New $57.00 Price Target at Wedbush
ETF DAILY NEWS· 2 days agoApellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price lowered by Wedbush from $67.00 to $57.00 in a research report report published on Wednesday morning, Benzinga reports ...
Short Interest in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Grows By 37.2%
ETF DAILY NEWS· 7 days agoAdverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 890,000 shares, a growth of ...
Ads
related to: Treatment Macular Degeneration